On January 22, 2026, Insilico Medicine announced a new ‘Science MMAI gym’ service designed to train general‑purpose LLMs such as GPT and Qwen to perform better on biology and chemistry tasks. The Hong Kong‑listed biotech says its pipeline can boost model performance by up to 10x on key scientific benchmarks using domain datasets, reward models and reinforcement learning.
This article aggregates reporting from 1 news source. The TL;DR is AI-generated from original reporting. Race to AGI's analysis provides editorial context on implications for AGI development.
Insilico’s “Science MMAI gym” is a concrete example of the emerging ecosystem around post‑training for specific, high‑value domains. Rather than building yet another frontier model, the company is positioning itself as the specialist that takes generalist systems like GPT or Qwen and beats them into shape on hard scientific tasks. The pitch is that you get the flexibility of a large general LLM with the precision of a domain model, all via RL, custom reward models and proprietary datasets. For AGI, this matters in two ways. First, it suggests that a lot of real‑world capability will come from layered adaptation, not just ever‑larger base models. Second, scientific reasoning—chemistry, biology, physics—is one of the hardest, highest‑impact domains to crack; better tools here accelerate drug discovery, materials science and eventually automated science agents. If services like Insilico’s become plug‑and‑play “science upgrades” for general models, they could sharply shorten the path from generic LLM to AI scientist. Strategically, it also shows how non‑Big‑Tech players can stay relevant in the AGI era: by owning domain expertise, data, and evaluation harnesses that the big labs don’t have or can’t easily replicate. Expect similar “gyms” to appear in law, finance, and engineering simulation as the stack around frontier models gets more modular.


